Federated Hermes
SANA icon

Federated Hermes’s Sana Biotechnology SANA Stock Holding History

Federated Hermes’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5
Closed -$8 – 2184
2024
Q4 		$8 Buy
5
+2
+67% +$6 ﹤0.01% 2065
2024
Q3 		$12 Buy
+3
New +$16 ﹤0.01% 2046
2023
Q1 		– Sell
-260,900
Closed -$1.03M – 2241
2022
Q4 		$1.03M Buy
+260,900
New +$1.28M ﹤0.01% 1123

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes's SANA Position: Q1 2025 in Review

Federated Hermes sold out of Sana Biotechnology (SANA) in Q1 2025, closing a stake of 5 shares — an estimated $8 sold.

Federated Hermes first reported a position in SANA in Q4 2022 and held it in 3 quarters. The position peaked at $1.03M in Q4 2022. 161 funds tracked by Wall St. Rank hold SANA as of Q1 2025.

  • Federated Hermes reported no remaining Sana Biotechnology position as of Q1 2025 after selling out during the quarter.
  • Federated Hermes sold 5 Sana Biotechnology shares in Q1 2025, an estimated $8.
  • Federated Hermes first reported a position in Sana Biotechnology in Q4 2022 and held it in 3 quarters.
  • Federated Hermes's Sana Biotechnology position peaked at $1.03M in Q4 2022.
  • 161 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2025.

Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.